MedGenie connects your unique genetic profile to every medication you take — delivering personalised safety information before adverse reactions occur.
Every person metabolises medications differently due to their genetic makeup. The same drug at the same dose can be safe for one patient — and life-threatening for another.
Yet today, most patients receive generic prescriptions with no consideration of their individual genetic profile. The result: preventable adverse reactions, hospitalisations, and deaths that could be avoided with personalised information.
MedGenie combines genetic data with real-time medication information to deliver actionable, personalised guidance at the point of care.
The patient's pharmacogenomic profile is securely stored — capturing the key gene variants that determine how their body processes medications.
Using the mymedgenie app, scan any medication barcode (US, Swiss, or European). MedGenie instantly retrieves the official drug label from FDA, Swissmedic, or EMA.
Within seconds, the patient receives a personalised safety report — specific interactions, dosage adjustments, and risks based on their individual genetic profile.
MedGenie's patented system bridges the gap between a patient's DNA and the medications they take — in real time, at scale.
Integrates with genetic test results to interpret CYP450 enzyme activity, drug transporter variants, and receptor polymorphisms — covering 100+ clinically actionable gene-drug pairs.
Our patented labelling approach translates complex pharmacogenomic interactions into clear, patient-friendly safety information — replacing technical jargon with actionable guidance.
Patients control their own genomic data. MedGenie is architected for full data sovereignty — no genomic data is shared without explicit patient consent.
Connected to FDA, Swissmedic, and EMA drug label databases via GS1 barcode standards — covering medications from the US, Switzerland, and across Europe.
The mymedgenie patient app puts personalised medication safety in your pocket. Scan any medication barcode from the US, Switzerland, or Europe and receive your personalised safety report instantly.
For the first time, patients can understand exactly how their body will respond to any medication — before taking it. MedGenie translates complex pharmacogenomic science into plain-language guidance you can act on.
MedGenie gives clinicians and pharmacists an evidence-based, patient-specific layer of safety information — integrated into the medication workflow to reduce adverse events and improve outcomes.
The global pharmacogenomics market is growing at 11% CAGR, driven by precision medicine mandates, falling genetic test costs, and regulatory push for personalised drug labelling.
MedGenie's pharmacogenomic medication labelling system is protected by a granted US patent — providing a durable competitive moat in the personalised medicine space.
MedGenie AG is a Swiss health technology company founded on the belief that every patient deserves medication safety information tailored to their unique genetic profile.
To eliminate preventable adverse drug reactions through personalised pharmacogenomic guidance — making precision medicine accessible to every patient, everywhere.
We invented a novel system that integrates individual genomic profiles with real-time drug label data and innovative safety labelling — protected by a granted US patent.
Headquartered in Bottmingen, Switzerland — we combine Swiss precision and reliability with a global vision for personalised healthcare.
Whether you're a patient seeking early access, a healthcare provider interested in a demo, or an investor exploring partnership opportunities — we'd love to hear from you.